Cargando…
Case–Control Study of Clostridium innocuum Infection, Taiwan
Vancomycin-resistant Clostridium innocuum was recently identified as an etiologic agent for antibiotic-associated diarrhea in humans. We conducted a case–control study involving 152 C. innocuum-infected patients during 2014–2019 in Taiwan, using 304 cases of Clostridioides difficile infection (CDI)...
Autores principales: | Chen, Yi-Ching, Kuo, Yi-Chun, Chen, Mi-Chi, Zhang, Young-Da, Chen, Chyi-Liang, Le, Puo-Hsien, Chiu, Cheng-Hsun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888209/ https://www.ncbi.nlm.nih.gov/pubmed/35195517 http://dx.doi.org/10.3201/eid2803.204421 |
Ejemplares similares
-
Clostridium innocuum, an emerging pathogen that induces lipid raft-mediated cytotoxicity
por: Wu, Hui-Yu, et al.
Publicado: (2023) -
Diversity and Prevalence of Clostridium innocuum in the Human Gut Microbiota
por: Bhattacharjee, Disha, et al.
Publicado: (2022) -
Peritonitis por Clostridium innocuum asociada a diálisis peritoneal
por: Aroca-Ferri, María, et al.
Publicado: (2019) -
Complete Genome Sequence of Clostridium innocuum Strain ATCC 14501
por: Cherny, K. E., et al.
Publicado: (2020) -
Fecal microbiota transplantation for treatment of refractory or recurrent Clostridioides difficile infection in Taiwan: a cost-effectiveness analysis
por: Lan, Kai-Yen, et al.
Publicado: (2023)